Strategic Oncology Enterprise Growth Lead
Quest Diagnostics
A complete application in a minute
Tailored resume and cover letter, ready to send.
Job summary
Quest Diagnostics is seeking a highly experienced Oncology Enterprise Solutions Business Development Executive to lead cross-regional collaboration and develop strategic plans across Advanced Oncology, Dermatology, Health Systems, and related franchises.
You will drive revenue through multi-disciplinary solutions, coordinating cross-functional teams and pursuing new business revenue streams with a focus on attrition immunity.
Qualifications
- Minimum 7 years of oncology, diagnostic, or life sciences key account experience.
- Experience in contract negotiations and high-level account management.
- B2B background with complex oncology customer organizations is preferred.
Responsibilities
- Create strategic oncology partnership opportunities with national oncology groups, academia, health systems, and specialty provider networks.
- Establish and strengthen relationships with c-suite executives across oncology, pathology, and healthcare systems.
- Develop mergers and acquisitions targets aligned with Quest Advanced and Ameripath strategies.
- Build and implement multi-modal solutions addressing the needs of market segments such as national oncology groups and large health systems.
- Create access through EMR/pathway inclusion and collaborate with cross-functional teams to drive demand.
- Align with Quest Diagnostic teams to propose and implement multi-modal solutions for client needs.
- Adhere to business acumen metrics including pipeline, productivity, and close rates.
Skills
Education
Tools
Job description
Quest Diagnostics is seeking a highly experienced Oncology Enterprise Solutions Business Development Executive to lead cross-regional collaboration and develop strategic plans across Advanced Oncology, Dermatology, Health Systems, and related franchises.
You will drive revenue through multi-disciplinary solutions, coordinating cross-functional teams and pursuing new business revenue streams with a focus on attrition immunity.
'/%3e%3cpath%20d='M101.744%2012.4726L102.894%2016.1947L99.0021%2013.2201L101.744%2012.4726ZM105.3%208.40937H100.488L99.0026%203.59473L97.5116%208.41047L92.7%208.40385L96.5965%2011.3834L95.1055%2016.1942L99.0021%2013.2196L101.408%2011.3834L105.3%208.40992V8.40937Z'%20fill='white'/%3e%3cdefs%3e%3clinearGradient%20id='paint0_linear_5593_1381'%20x1='90'%20y1='9.44471'%20x2='99'%20y2='9.44471'%20gradientUnits='userSpaceOnUse'%3e%3cstop%20stop-color='%2300AD70'/%3e%3cstop%20offset='0.998594'%20stop-color='%2300B67A'/%3e%3cstop%20offset='1'%20stop-color='%23DCDCE6'/%3e%3c/linearGradient%3e%3c/defs%3e%3c/svg%3e){kind=small}
